|
MX2007012054A
|
|
Pazufloxacin ophthalmic formulation.
|
|
MX2007011165A
|
|
Pharmaceutically stable compound consisting of timolol, dorzolamide and brimonidine.
|
|
MX2007010025A
|
|
Pharmaceutical composition for treatment of ocular hypertension.
|
|
MX2007002802A
|
|
Implants and microspheres for the sustained release of drugs for ophthalmic use and preparation methods thereof.
|
|
BR0318395A
|
|
method for preparing an aqueous meloxicam solution and the resulting aqueous solution
|
|
MXJL02000046A
|
|
Intravitreous injectable solution for the treatment of vitreous hemorrhages.
|
|
MXPA02012274A
|
|
Physioelectric multistimulator controlled by the parallel port (lpt1)with graphic interface and sonorous detector of nervous ramifications.
|
|
MXPA02005472A
|
|
Formulation of a hyaluronic acid-based viscoelastic substance useful in cataract intraocular surgery.
|
|
MXPA01013257A
|
|
Rofecoxib ophthalmic suspension for the treatment of ocular inflammation and pain.
|
|
MX9701946A
|
|
Transporting ophthalmic solution.
|
